Affordable Access

deepdyve-link deepdyve-link
Publisher Website

[Off-label therapy: current problems from the perspective of the Pharmaceutical Commission of the German Medical Profession].

Authors
Type
Published Article
Journal
Zeitschrift für Rheumatologie
Publication Date
Volume
71
Issue
2
Identifiers
DOI: 10.1007/s00393-011-0901-8
PMID: 22370801
Source
Medline
License
Unknown

Abstract

The off-label use of approved pharmaceuticals outside the authorized status is implemented in pharmacotherapy of many diseases, especially for rare diseases and in cases of therapy resistance. The German regulations are presented and analyzed and the relative literature is discussed.

Statistics

Seen <100 times